C. Ávila-Figueroa

发表

How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries

D. Shepard, J. Chilingerian, W. Zeng, 2012, BMC Health Services Research.

Efficiency of HIV/AIDS Health Centers and Effect of Community-Based Health Insurance and Performance-Based Financing on HIV/AIDS Service Delivery in Rwanda

Wu Zeng, Donald S. Shepard, D. Shepard, 2014, The American journal of tropical medicine and hygiene.

Resource needs and gap analysis in achieving universal access to HIV/AIDS services: a data envelopment analysis of 45 countries.

D. Shepard, W. Zeng, C. Ávila-Figueroa, 2016, Health Policy and Planning.

Uniting the world against AIDS 1 Novel and Alternative Approaches to Estimate Global Resource Needs to HIV and AIDS

D. Shepard, W. Zeng, C. Ávila-Figueroa, 2007 .

Critical Review of Costing Models to Estimate Resource Needs to Address Global HIV and AIDS

D. Shepard, W. Zeng, C. Ávila-Figueroa, 2007 .

Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center.

C. Ávila-Figueroa, L. E. Espinosa de los Monteros, I. M. Bustos, 2001, The Pediatric infectious disease journal.

Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries

P. D. De Lay, C. Ávila-Figueroa, Peter Amico, 2012, BMC Public Health.

Resource flows and levels of spending for the response to HIV and AIDS in Belarus

C. Ávila-Figueroa, Peter Amico, Anna Yakusik, 2011, BMC Research Notes.

Financing the Response to HIV in Low-Income and Middle-Income Countries

C. Ávila-Figueroa, T. Guthrie, C. Arán, 2009, Journal of acquired immune deficiency syndromes.

A Controlled Study of Funding for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome as Resource Capacity Building in the Health System in Rwanda

D. Shepard, W. Zeng, C. Ávila-Figueroa, 2012, The American journal of tropical medicine and hygiene.

[FARMAC: a program designed for monitoring the prescription of antimicrobials in hospitals].

C. Ávila-Figueroa, J. Santos-Preciado, S. Navarrete-Navarro, 2000, Gaceta medica de Mexico.

Mortality associated with systemic candidiasis in children.

C. Ávila-Figueroa, J. I. Santos, A. Pacheco-Ríos, 1997, Archives of medical research.

[Clinical manifestations of infection by human immunodeficiency virus in children].

C. Ávila-Figueroa, P. Valencia-Mayoral, N. Pavía-Ruz, 1989, Boletin medico del Hospital Infantil de Mexico.

Prevalence of oral lesions in Mexican children with perinatally acquired HIV: association with immunologic status, viral load, and gender.

C. Ávila-Figueroa, L. Gaitán-Cepeda, L. Sánchez-Vargas, 2002, AIDS patient care and STDs.

A prospective study of surgical site infections in a pediatric hospital in Mexico City.

C. Ávila-Figueroa, R. Ordorica-Flores, D. Vilar-Compte, 2003, American journal of infection control.

Improved serological response to human diploid cell rabies vaccine when given simultaneously with antirabies hyperimmune globulin.

C. Ávila-Figueroa, Á. Aguilar-Setién, J. Santos-Preciado, 1999, Archives of medical research.

Country response to HIV/AIDS: National Health Accounts on HIV/AIDS in Brazil, Guatemala, Honduras, Mexico and Uruguay

C. Ávila-Figueroa, Patricia Hernández, J. Izazola-Licea, 2002, AIDS.

Intravenous lipid emulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birth weight newborns.

D. Richardson, J. Gray, D. Goldmann, 1998, The Pediatric infectious disease journal.

Asia can afford universal access for AIDS prevention and treatment

T. Brown, R. Atun, C. Ávila-Figueroa, 2010, AIDS.

Methods for the Quality of Life Assessment

C. Ávila-Figueroa, Elizabeth Velarde-Jurado, 2004 .

Levels of Spending and Resource Allocation to HIV Programs and Services in Latin America and the Caribbean

C. Ávila-Figueroa, Peter Amico, J. Izazola-Licea, 2011, PloS one.

Extrinsic contamination of intravenous infusates administered to hospitalized children in Mexico.

C. Ávila-Figueroa, J. Gaitán-Meza, I. Hernandez-Ramos, 2000, The Pediatric infectious disease journal.

[Incidence of nosocomial bacteremia and pneumonia in pediatric unit].

C. Ávila-Figueroa, G. Martínez-Aguilar, M. C. Anaya-Arriaga, 2001, Salud publica de Mexico.

[Candida endocarditis in the first year of life].

C. Ávila-Figueroa, J. Santos-Preciado, M. Cashat-Cruz, 1993, Boletin medico del Hospital Infantil de Mexico.

Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.

S. Bertozzi, C. Ávila-Figueroa, K. Rely, 2003, Health policy and planning.

[Prevalence of nosocomial infections in children: survey of 21 hospitals in Mexico].

C. Ávila-Figueroa, R. Becerril, M. Cashat-Cruz, 1999, Salud publica de Mexico.

[Protection of health personnel against hepatitis B by DNA recombinant vaccine].

C. Ávila-Figueroa, J. Santos-Preciado, S. Navarrete-Navarro, 1992, Boletín Médico del Hospital Infantil de México.

Utilization Patterns and Projected Demand of Antiretroviral Drugs in Low- and Middle-Income Countries

C. Ávila-Figueroa, J. Stover, Y. Souteyrand, 2011, AIDS research and treatment.